Dare Bioscience, Inc.
DARE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001401914
No open-market purchases or sales by Dare Bioscience, Inc. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $2.75M in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Dare Bioscience, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 40 | 36 | −4 |
| Shares | 6.64M | 7.42M | +774.9K (+11.7%) |
| Value | $9.89M | $9.12M | −$768.3K (−7.8%) |
New holders (5)
Institutions that held Dare Bioscience, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Founders Financial Securities LLC | 103,500 | $127.0K | 0.02% |
| Founders Financial Alliance, LLC | 102,500 | $126.0K | 0.06% |
| Virtu Financial LLC | 52,819 | $65.0K | 0.01% |
| Cubist Systematic Strategies, LLC | 16,839 | $21.0K | 0.00% |
| Susquehanna International Group, LLP | 10,403 | $13.0K | 0.00% |
Sold out (9)
Institutions that held Dare Bioscience, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Marshall Wace, LLP | 73,680 | $110.0K |
| ExodusPoint Capital Management, LP | 72,656 | $108.0K |
| Jane Street Group, LLC | 58,607 | $87.0K |
| Citadel Advisors LLC | 42,378 | $63.0K |
| Buckingham Strategic Partners | 30,000 | $45.0K |
| Bank of America Corp | 29,673 | $44.0K |
| Citigroup Inc | 26,540 | $40.0K |
| Squarepoint Ops LLC | 11,618 | $17.0K |
| Tortoise Investment Management, LLC | 750 | $1.00K |